Loading organizations...
Biotechnology company developing targeted therapies for cancer treatment.
Adcentrx Therapeutics has raised $51.0M across 2 funding rounds.
Adcentrx Therapeutics has raised $51.0M in total across 2 funding rounds.
Adcentrx Therapeutics has raised $51.0M in total across 2 funding rounds.
Adcentrx Therapeutics's investors include Partners Investment, Quan Capital, Tao Huang, Jeffrey Jonas, Delta Capital, F-Prime Capital, Trinity Innovation Fund.
Adcentrx Therapeutics has raised $51.0M across 2 funding rounds. Most recently, it raised $13.0M Series A Extension in December 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 6, 2023 | $13.0M Series A Extension | Partners Investment, Quan Capital, Tao Huang | Jeffrey Jonas |
| Apr 25, 2023 | $38.0M Series A | Tao Huang | Jeffrey Jonas, Delta Capital, F-Prime Capital, Trinity Innovation Fund |